These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35381275)
1. High dose rate brachytherapy in the management of anal cancer: A review. Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275 [TBL] [Abstract][Full Text] [Related]
2. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers. Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606 [TBL] [Abstract][Full Text] [Related]
3. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers. Varela Cagetti L; Zemmour C; Salem N; Minsat M; Ferrè M; Mailleux H; Giovaninni M; Lelong B; De Chaisemartin C; Ries P; Poizat F; Tallet A; Moureau-Zabotto L Brachytherapy; 2019; 18(6):814-822. PubMed ID: 31515067 [TBL] [Abstract][Full Text] [Related]
4. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review. Buckley H; Wilson C; Ajithkumar T Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):111-127. PubMed ID: 28816137 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244 [TBL] [Abstract][Full Text] [Related]
6. To evaluate the use of tandem and cylinder as an intracavitary brachytherapy device for carcinoma of the cervix with regard to local control and toxicities. Gadda IR; Khan NA; Wani SQ; Baba MH J Cancer Res Ther; 2022; 18(3):740-746. PubMed ID: 35900548 [TBL] [Abstract][Full Text] [Related]
7. Interstitial high-dose rate brachytherapy as boost for anal canal cancer. Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886 [TBL] [Abstract][Full Text] [Related]
8. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240 [TBL] [Abstract][Full Text] [Related]
9. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma? Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850 [TBL] [Abstract][Full Text] [Related]
10. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929 [TBL] [Abstract][Full Text] [Related]
11. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients. Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539 [TBL] [Abstract][Full Text] [Related]
12. Outcome of 6 fractions of 5.3 Gray HDR brachytherapy in combination with external beam radiotherapy for treatment of cervical cancer. Koh WY; Lim K; Tey J; Lee KM; Lim GH; Choo BA Gynecol Oncol; 2013 Oct; 131(1):93-8. PubMed ID: 23906655 [TBL] [Abstract][Full Text] [Related]
13. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653 [TBL] [Abstract][Full Text] [Related]
14. The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatments. Varela Cagetti L; Moureau-Zabotto L; Zemmour C; Ferré M; Giovaninni M; Poizat F; Lelong B; De Chaisemartin C; Mitry E; Tyran M; Zioueche-Mottet A; Salem N; Tallet A Brachytherapy; 2023; 22(4):531-541. PubMed ID: 37150739 [TBL] [Abstract][Full Text] [Related]
16. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer. Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045 [TBL] [Abstract][Full Text] [Related]
17. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients]. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857 [TBL] [Abstract][Full Text] [Related]
18. Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary? Kovács G; Galalae R Cancer Radiother; 2003 Apr; 7(2):100-6. PubMed ID: 12719039 [TBL] [Abstract][Full Text] [Related]
19. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer. Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631 [TBL] [Abstract][Full Text] [Related]
20. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Huart J; Pène F; Schlienger M Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1259-73. PubMed ID: 12873670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]